Proteome Sciences (LON:PRM) Reaches New 52-Week Low – Here’s Why

by · The Cerbat Gem

Proteome Sciences plc (LON:PRM – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 1.40 and last traded at GBX 1.40, with a volume of 46676 shares. The stock had previously closed at GBX 1.69.

Proteome Sciences Stock Up 14.5%

The stock has a market capitalization of £5.56 million, a price-to-earnings ratio of -1.67 and a beta of 0.07. The business has a fifty day moving average of GBX 1.96 and a 200 day moving average of GBX 2.74. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.

Proteome Sciences (LON:PRM – Get Free Report) last posted its earnings results on Thursday, September 25th. The company reported GBX (0.73) earnings per share (EPS) for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Company Profile

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Recommended Stories